Helen Conroy

1.4k total citations
12 papers, 1.2k citations indexed

About

Helen Conroy is a scholar working on Immunology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Helen Conroy has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Helen Conroy's work include Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (3 papers) and Nuclear Receptors and Signaling (2 papers). Helen Conroy is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (3 papers) and Nuclear Receptors and Signaling (2 papers). Helen Conroy collaborates with scholars based in Ireland, United States and Canada. Helen Conroy's co-authors include Emma M. Creagh, Séamus J. Martin, Kingston H. G. Mills, Seamas C. Donnelly, Leona Mawhinney, Neil A. Marshall, Alain Charest, Julie Park, Keara Lane and Kevin McMahon and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Oncogene.

In The Last Decade

Helen Conroy

12 papers receiving 1.1k citations

Peers

Helen Conroy
Kristen Page United States
Ines Eue Germany
Glen M. Scholz Australia
Joseph J. Lucas United States
Mark Baer United States
Fred Wong Canada
C Gallegos United States
Helen Conroy
Citations per year, relative to Helen Conroy Helen Conroy (= 1×) peers Vito Ruggiero

Countries citing papers authored by Helen Conroy

Since Specialization
Citations

This map shows the geographic impact of Helen Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Conroy more than expected).

Fields of papers citing papers by Helen Conroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Conroy. The network helps show where Helen Conroy may publish in the future.

Co-authorship network of co-authors of Helen Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Conroy. A scholar is included among the top collaborators of Helen Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Conroy. Helen Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mawhinney, Leona, Michelle E. Armstrong, Ciaran O’Reilly, et al.. (2014). Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer. Molecular Medicine. 20(1). 729–735. 53 indexed citations
2.
Conroy, Helen, Karen Galvin, Sarah Higgins, & Kingston H. G. Mills. (2011). Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells. Cancer Immunology Immunotherapy. 61(3). 425–431. 41 indexed citations
3.
Conroy, Helen, Leona Mawhinney, & Seamas C. Donnelly. (2010). Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link. QJM. 103(11). 831–836. 161 indexed citations
4.
Jarnicki, Andrew, Helen Conroy, Corinna F. Brereton, et al.. (2008). Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics. The Journal of Immunology. 180(6). 3797–3806. 114 indexed citations
5.
Conroy, Helen, Neil A. Marshall, & Kingston H. G. Mills. (2008). TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene. 27(2). 168–180. 138 indexed citations
6.
Toomey, Deirdre, Helen Conroy, Andrew Jarnicki, et al.. (2008). Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma. Vaccine. 26(27-28). 3540–3549. 24 indexed citations
7.
Conroy, Helen. (2007). Skills for the information age. Perspectives Policy and Practice in Higher Education. 11(1). 18–24. 3 indexed citations
9.
Creagh, Emma M., Helen Conroy, & Séamus J. Martin. (2003). Caspase‐activation pathways in apoptosis and immunity. Immunological Reviews. 193(1). 10–21. 303 indexed citations
10.
Charest, Alain, Keara Lane, Kevin McMahon, et al.. (2003). Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21). Genes Chromosomes and Cancer. 37(1). 58–71. 153 indexed citations
11.
Bouchier‐Hayes, Lisa, Helen Conroy, Colin Adrain, et al.. (2001). CARDINAL, a Novel Caspase Recruitment Domain Protein, Is an Inhibitor of Multiple NF-κB Activation Pathways. Journal of Biological Chemistry. 276(47). 44069–44077. 96 indexed citations
12.
Bouchier‐Hayes, Lisa, Helen Conroy, Colin Adrain, et al.. (2001). Bouchier-Hayes, L. et al. CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-B activation pathways. J. Biol. Chem. 276, 44069-44077. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026